BiomX Completes Strategic Pivot to Defense and Security Technology Sector

BiomX Inc. (NYSE American: PHGE) has issued a press release and updated investor presentation detailing its completed strategic transition from a clinical-stage biotechnology company to a defense and security technology holding company. The company is now focused on acquiring and developing technologies that identify, analyze, and respond to physical threats, particularly those posed by UAVs and autonomous systems. The current portfolio includes Zorronet, an AI-powered autonomous C5ISR platform, and Dr. Frucht Systems Ltd (DFSL), which specializes in LADAR-based threat detection. BiomX holds a 100% stake in Zorronet and a 60% stake in DFSL. The presentation highlights established relationships with major defense contractors like Elbit Systems and Rafael Advanced Defense Systems. Additionally, the company is actively implementing a compliance plan to regain and maintain its listing on the NYSE American exchange. The leadership team has been restructured to include experts from the defense, intelligence, and security sectors to support this new strategic direction.